RESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple attack on pancreatic cancer: new hope for patients
Disease control Recruiting nowThis study tests a new approach for people with pancreatic cancer that can be surgically removed. Before surgery, patients receive a combination of chemotherapy, immunotherapy, and targeted radiation. After surgery, they continue with chemotherapy and immunotherapy. The goal is t…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New hope for pancreatic cancer: targeted pill may double remission time
Disease control Recruiting nowThis study tests whether a daily pill called olaparib can keep pancreatic cancer from returning after surgery and chemotherapy. It is for people whose tumors have specific gene mutations (BRCA1, BRCA2, or PALB2). About 152 participants will receive either olaparib or a placebo fo…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New chemo cocktail aims to shrink pancreatic tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of three chemotherapy drugs (gemcitabine, cisplatin, and nab-paclitaxel) before surgery can help shrink pancreatic tumors and improve outcomes. About 36 adults with pancreatic cancer that can be surgically removed will participate. Th…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Pancreatic cancer weight loss mystery: genes may hold the key
Knowledge-focused Recruiting nowThis study aims to understand why some pancreatic cancer patients lose weight and muscle (cachexia) more than others. Researchers will compare genes and weight changes in 100 patients, with a focus on African Americans. The goal is to find patterns that could lead to better care …
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC